This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cheleuitte, D. Articles by Glowacki, J. Search for Related Content PubMed PubMed Citation Articles by Cheleuitte, D. Articles by Glowacki, J.

In Vitro Secretion of Cytokines by Human Bone Marrow: Effects of Age and Estrogen Status¹

Department of Orthopedic Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02115

Address all correspondence and requests for reprints to: Julie Glowacki, Ph.D., Orthopedic Research, Brigham and Women’s Hospital, 75 Francis Street, Boston, Massachusetts 02115.

It has been proposed that cytokines mediate the acceleration of bone loss following menopause. Because of the intimate relationship between bone marrow stromal cells and bone tissue, it is possible that marrow cells and their products contribute to the bone microenvironment and influence the regulation of bone cell differentiation and activity. We examined the production of cytokines by bone marrow stromal cells from a total of 37 women and 15 men undergoing total hip replacement for noninflammatory joint disease. Low-density mononuclear cells were isolated from bone marrow and were cultured in phenol red-free MEM medium supplemented with 10% FBS and antibiotics. Constitutive secretion of interleukin-6 (IL-6) was positively correlated with age in a series of 8 women and 5 men measured by bioassay (r = 0.98; P < 0.01) and in a series of 18 women and 10 men measured by immunoassay (r = 0.56; P < 0.01). The pattern of cytokine production by bone marrow stromal cells was examined in detail in 23 postmenopausal women, aged 49–88 yr. Basal secretion of immunoreactive IL-6 and IL-11, but not granulocyte-macrophage colony-stimulating factor, increased with time in culture. Exogenous IL-1ß stimulated secretion of IL-6 and IL-11 in a saturable, dose-dependent manner. Secretion of soluble IL-6 receptor was not correlated with secretion of IL-6, either constitutively or in the presence of IL-1ß. In 4 of 14 samples, IL-1ß also stimulated secretion of granulocyte-macrophage colony-stimulating factor. IL-1ß was undetectable in 7 of 9 cultures during the 2-week culture period. IL-6 did not stimulate secretion of IL-1ß in the 7 cultures tested. Cells were dependent upon serum for viability and growth and were not sustained by a serum substitute (1% insulin-transferrin-selenium-BSA). Cells grown in medium with 10% FBS and supplemented with 1% insulin-transferrin-selenium-BSA secreted 10-fold more IL-6 than cells grown in serum alone. Marrow from 7 women receiving estrogen replacement therapy showed lower constitutive secretion of IL-6 (75%; P < 0.006) and IL-11 (43%; P < 0.05) than marrow from age-matched controls and had blunted stimulation of IL-6 and IL-11 secretion by exogenous IL-1ß. These data indicate distinct patterns of cytokine production by human marrow stromal cultures dependent upon age and estrogen status.

This article has been cited by other articles:

				K. R. Belsito, B. M. Vester, T. Keel, T. K. Graves, and K. S. Swanson Impact of ovariohysterectomy and food intake on body composition, physical activity, and adipose gene expression in cats J Anim Sci, February 1, 2009; 87(2): 594 - 602. [Abstract] [Full Text] [PDF]

				J. L. Turgeon, M. C. Carr, P. M. Maki, M. E. Mendelsohn, and P. M. Wise Complex Actions of Sex Steroids in Adipose Tissue, the Cardiovascular System, and Brain: Insights from Basic Science and Clinical Studies Endocr. Rev., October 1, 2006; 27(6): 575 - 605. [Abstract] [Full Text] [PDF]

				Y. Zhang, T. R. Holford, B. Leaderer, P. Boyle, S. H. Zahm, B. Zhang, K. Zou, L. M. Morton, P. H. Owens, S. Flynn, et al. Menstrual and Reproductive Factors and Risk of Non-Hodgkin's Lymphoma among Connecticut Women Am. J. Epidemiol., October 15, 2004; 160(8): 766 - 773. [Abstract] [Full Text] [PDF]

				R. D. Blumenthal, A. Reising, E. Leon, and D. M. Goldenberg Modulation of Marrow Proliferation and Chemosensitivity by Tumor-produced Cytokines from Syngeneic Pancreatic Tumor Lines Clin. Cancer Res., May 1, 2002; 8(5): 1301 - 1309. [Abstract] [Full Text] [PDF]

				J. Pfeilschifter, R. Koditz, M. Pfohl, and H. Schatz Changes in Proinflammatory Cytokine Activity after Menopause Endocr. Rev., February 1, 2002; 23(1): 90 - 119. [Abstract] [Full Text] [PDF]

				D. M. Herrington, K. B. Brosnihan, B. E. Pusser, E. W. Seely, P. M. Ridker, N. Rifai, and D. B. MacLean Differential Effects of E and Droloxifene on C-Reactive Protein and Other Markers of Inflammation in Healthy Postmenopausal Women J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4216 - 4222. [Abstract] [Full Text] [PDF]

				R. A. Nelson, A. M. Levine, and L. Bernstein Reproductive Factors and Risk of Intermediate- or High-Grade B-Cell Non-Hodgkin's Lymphoma in Women J. Clin. Oncol., March 1, 2001; 19(5): 1381 - 1387. [Abstract] [Full Text] [PDF]

				A. A. Beharka, M. Meydani, D. Wu, L. S. Leka, A. Meydani, and S. N. Meydani Interleukin-6 Production Does Not Increase With Age J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2001; 56(2): 81B - 88. [Abstract] [Full Text]

				S. C. Manolagas Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis Endocr. Rev., April 1, 2000; 21(2): 115 - 137. [Abstract] [Full Text]

				C. Libanati, D. J. Baylink, E. Lois-Wenzel, N. Srinivasan, and S. Mohan Studies on the Potential Mediators of Skeletal Changes Occurring during Puberty in Girls J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2807 - 2814. [Abstract] [Full Text]